Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Current Deferred Revenue (2016 - 2026)

Bio-Techne has reported Current Deferred Revenue over the past 12 years, most recently at $33.0 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 8.55% year-over-year to $33.0 million; the TTM value through Dec 2025 reached $33.0 million, up 8.55%, while the annual FY2025 figure was $35.3 million, 26.39% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $33.0 million at Bio-Techne, up from $32.7 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $35.6 million in Q1 2025 and troughed at $18.7 million in Q1 2021.
  • A 5-year average of $26.8 million and a median of $26.2 million in 2023 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: surged 45.57% in 2021 and later fell 3.53% in 2023.
  • Year by year, Current Deferred Revenue stood at $19.1 million in 2021, then increased by 23.16% to $23.5 million in 2022, then grew by 28.09% to $30.1 million in 2023, then grew by 1.0% to $30.4 million in 2024, then increased by 8.55% to $33.0 million in 2025.
  • Business Quant data shows Current Deferred Revenue for TECH at $33.0 million in Q4 2025, $32.7 million in Q3 2025, and $35.3 million in Q2 2025.